Nathan C. Karpilovsky
Montreal, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
N-terminal acetylation reduces synuclein pathology in models of Parkinson's disease.
Journal: Neurobiology of disease
Published: March 29, 2026
Correction: The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.
Journal: Molecular neurodegeneration
Published: December 19, 2024
The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.
Journal: Research square
Published: April 02, 2024
Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 28, 2024
The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.
Journal: Molecular neurodegeneration
Published: February 22, 2024
The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.
Journal: bioRxiv : the preprint server for biology
Published: November 28, 2023
An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders.
Journal: Molecular neurodegeneration
Published: September 11, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026